Treatment of delta-like 1 homolog (dlk1) related diseases by...

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/63 (2006.01) C12N 15/113 (2010.01) A61K 48/00 (2006.01) C07H 21/00 (2006.01) C12Q 1/68 (2006.01)

Patent

CA 2755404

The present invention relates to antisense oligonucleotides that modulate the expression of and / or function of Delta- like (1) homolog (DLK1), in particular, by targeting natural antisense polynucleotides of Delta-like (1) homolog (DLK1). The invention also relates to the identification of these antisense oligonucleotides and their use in treating diseases and disorders associated with the expression of (DLK1).

Cette invention concerne des oligonucléotides antisens qui modulent l'expression et/ou la fonction de l'homologue du Delta-like (1) (DLK1), en particulier, par ciblage des polynucléotides antisens naturels de l'homologue du Delta-like (1) (DLK1). L'invention concerne également l'identification de ces oligonucléotides antisens et leur utilisation pour traiter les maladies et les troubles associés à l'expression de (DLK1).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of delta-like 1 homolog (dlk1) related diseases by... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of delta-like 1 homolog (dlk1) related diseases by..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of delta-like 1 homolog (dlk1) related diseases by... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1782875

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.